SCHEMBL7574847

SCHEMBL7574847

CCOC(=O)C1C(=O)c2ccc(Br)cc2N(C2CC2)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 1/20 0.48
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 2/20 0.40
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
TSHR P16473 2/20 0.38
APAF1 O14727 1/20 0.38
SMAD3 P84022 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KDM4E B2RXH2 3/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
GABRA1 P14867 3/20 0.37
GABRG2 P18507 3/20 0.37
GABRB3 P28472 3/20 0.37
GABRA5 P31644 3/20 0.37
GABRA3 P34903 3/20 0.37
GABRA2 P47869 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14796340 0.81 TDP2 (0.49) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL7576603 0.78 ALDH1A1 (0.37) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL7585605 0.74 KDM4E (0.34) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL7896613 0.72 MAPT (0.36) ALDH1A1MAPK1MEN1KMT2ATSHR
SCHEMBL30099690 0.68 ALDH1A1 (0.55) ALDH1A1MAPK1MEN1KMT2AL3MBTL1
SCHEMBL30438181 0.68 MEN1 (0.53) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL22070762 0.68 MEN1 (0.50) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL19900425 0.68 MEN1 (0.53) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL15825184 0.67 KMT2A (0.72) TDP2ALDH1A1MAPK1MEN1KMT2A
SCHEMBL18989089 0.66 TDP2 (0.41) TDP2ALDH1A1MAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials ABBOTT LABORATORIES 2002-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049223-A1 Quinoline and naphthyridine carboxylic acid antibacterials NQO2, NQO1, NDUFA7 TDP2 3951/4885ALDH1A1 145/4885MAPK1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.